This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Debaraj Mukherjee: Innovator in Cancer Research
Introduction
Debaraj Mukherjee is a notable inventor based in Jammu, India. He has made significant contributions to the field of cancer research through his innovative work. His research focuses on developing compounds that can inhibit cancer cell invasion and metastasis.
Latest Patents
Debaraj Mukherjee holds a patent for "Indolylkojyl methane analogues, process of preparation thereof and use as inhibitor of cancer cells invasion and metastasis." This invention discloses novel indolylkojyl compounds that are selectively toxic towards human breast cancer cells. The compounds inhibit tumor growth and lung metastasis, while also enhancing the effects of anticancer drugs. The invention provides a one-pot, green chemistry method for the preparation of these compounds.
Career Highlights
Debaraj Mukherjee is associated with the Council of Scientific and Industrial Research, where he continues to advance his research in cancer therapeutics. His work has the potential to significantly impact cancer treatment and improve patient outcomes.
Collaborations
He collaborates with esteemed colleagues such as Anindya Goswami and Deepak Kumar Sharma, contributing to a dynamic research environment focused on innovative solutions in cancer treatment.
Conclusion
Debaraj Mukherjee's contributions to cancer research through his patented inventions highlight the importance of innovation in the medical field. His work exemplifies the potential of scientific research to lead to breakthroughs in cancer therapy.